EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Abstract Background The availability of a reliable tumor target for advanced colorectal cancer (CRC) therapeutic approaches is critical since current treatments are limited. Epidermal growth factor-like domain 6 (EGFL6) has been reported to be associated with cancer development. Here, we focused on...
Main Authors: | Ting-Yi Sung, Han-Li Huang, Chun-Chun Cheng, Fu-Ling Chang, Po-Li Wei, Ya-Wen Cheng, Cheng-Chiao Huang, Yu-Ching Lee, Wei-Chun HuangFu, Shiow-Lin Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-021-00561-0 |
Similar Items
-
egfl6 expression in the pharyngeal pouch is dispensable for craniofacial development
by: Sil Jin, et al.
Published: (2021-08-01) -
Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
by: Lan Xiaolei, et al.
Published: (2019-12-01) -
Anti-EGFL7 antibodies inhibit rat prolactinoma MMQ cells proliferation and PRL secretion
by: Liu Qian, et al.
Published: (2018-07-01) -
Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
by: Wenhui Zhu, et al.
Published: (2020-08-01) -
Characterization of the Drosophila Egfl7/8 ortholog during oogenesis
by: Bielli, Serena
Published: (2006)